[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Clinical Trials Market Size, Status and Forecast 2020-2026

September 2020 | 94 pages | ID: C6488BF830A3EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Clinical Trials status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Trials development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • Quintiles IMS
  • Paraxel International Corporation
  • Charles River Laboratories
  • ICON plc
  • SGS SA
  • Pharmaceutical Product Development, LLC
  • Wuxi AppTec Inc.
  • PRA Health Sciences
  • Chiltern International Ltd.
  • INC Research
Market segment by Type, the product can be split into
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Market segment by Application, split into
  • Interventional
  • Observational
  • Expanded Access
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Clinical Trials status, future forecast, growth opportunity, key market and key players.
  • To present the Clinical Trials development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Clinical Trials are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Clinical Trials Revenue
1.4 Market Analysis by Type
  1.4.1 Global Clinical Trials Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Phase I
  1.4.3 Phase II
  1.4.4 Phase III
  1.4.5 Phase IV
1.5 Market by Application
  1.5.1 Global Clinical Trials Market Share by Application: 2020 VS 2026
  1.5.2 Interventional
  1.5.3 Observational
  1.5.4 Expanded Access
1.6 Coronavirus Disease 2019 (Covid-19): Clinical Trials Industry Impact
  1.6.1 How the Covid-19 is Affecting the Clinical Trials Industry
    1.6.1.1 Clinical Trials Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Clinical Trials Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Clinical Trials Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Clinical Trials Market Perspective (2015-2026)
2.2 Clinical Trials Growth Trends by Regions
  2.2.1 Clinical Trials Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Clinical Trials Historic Market Share by Regions (2015-2020)
  2.2.3 Clinical Trials Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Clinical Trials Market Growth Strategy
  2.3.6 Primary Interviews with Key Clinical Trials Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Clinical Trials Players by Market Size
  3.1.1 Global Top Clinical Trials Players by Revenue (2015-2020)
  3.1.2 Global Clinical Trials Revenue Market Share by Players (2015-2020)
  3.1.3 Global Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Clinical Trials Market Concentration Ratio
  3.2.1 Global Clinical Trials Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Clinical Trials Revenue in 2019
3.3 Clinical Trials Key Players Head office and Area Served
3.4 Key Players Clinical Trials Product Solution and Service
3.5 Date of Enter into Clinical Trials Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Clinical Trials Historic Market Size by Type (2015-2020)
4.2 Global Clinical Trials Forecasted Market Size by Type (2021-2026)

5 CLINICAL TRIALS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Clinical Trials Market Size by Application (2015-2020)
5.2 Global Clinical Trials Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Clinical Trials Market Size (2015-2020)
6.2 Clinical Trials Key Players in North America (2019-2020)
6.3 North America Clinical Trials Market Size by Type (2015-2020)
6.4 North America Clinical Trials Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Clinical Trials Market Size (2015-2020)
7.2 Clinical Trials Key Players in Europe (2019-2020)
7.3 Europe Clinical Trials Market Size by Type (2015-2020)
7.4 Europe Clinical Trials Market Size by Application (2015-2020)

8 CHINA

8.1 China Clinical Trials Market Size (2015-2020)
8.2 Clinical Trials Key Players in China (2019-2020)
8.3 China Clinical Trials Market Size by Type (2015-2020)
8.4 China Clinical Trials Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Clinical Trials Market Size (2015-2020)
9.2 Clinical Trials Key Players in Japan (2019-2020)
9.3 Japan Clinical Trials Market Size by Type (2015-2020)
9.4 Japan Clinical Trials Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Clinical Trials Market Size (2015-2020)
10.2 Clinical Trials Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Clinical Trials Market Size by Type (2015-2020)
10.4 Southeast Asia Clinical Trials Market Size by Application (2015-2020)

11 INDIA

11.1 India Clinical Trials Market Size (2015-2020)
11.2 Clinical Trials Key Players in India (2019-2020)
11.3 India Clinical Trials Market Size by Type (2015-2020)
11.4 India Clinical Trials Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Clinical Trials Market Size (2015-2020)
12.2 Clinical Trials Key Players in Central & South America (2019-2020)
12.3 Central & South America Clinical Trials Market Size by Type (2015-2020)
12.4 Central & South America Clinical Trials Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Quintiles IMS
  13.1.1 Quintiles IMS Company Details
  13.1.2 Quintiles IMS Business Overview and Its Total Revenue
  13.1.3 Quintiles IMS Clinical Trials Introduction
  13.1.4 Quintiles IMS Revenue in Clinical Trials Business (2015-2020))
  13.1.5 Quintiles IMS Recent Development
13.2 Paraxel International Corporation
  13.2.1 Paraxel International Corporation Company Details
  13.2.2 Paraxel International Corporation Business Overview and Its Total Revenue
  13.2.3 Paraxel International Corporation Clinical Trials Introduction
  13.2.4 Paraxel International Corporation Revenue in Clinical Trials Business (2015-2020)
  13.2.5 Paraxel International Corporation Recent Development
13.3 Charles River Laboratories
  13.3.1 Charles River Laboratories Company Details
  13.3.2 Charles River Laboratories Business Overview and Its Total Revenue
  13.3.3 Charles River Laboratories Clinical Trials Introduction
  13.3.4 Charles River Laboratories Revenue in Clinical Trials Business (2015-2020)
  13.3.5 Charles River Laboratories Recent Development
13.4 ICON plc
  13.4.1 ICON plc Company Details
  13.4.2 ICON plc Business Overview and Its Total Revenue
  13.4.3 ICON plc Clinical Trials Introduction
  13.4.4 ICON plc Revenue in Clinical Trials Business (2015-2020)
  13.4.5 ICON plc Recent Development
13.5 SGS SA
  13.5.1 SGS SA Company Details
  13.5.2 SGS SA Business Overview and Its Total Revenue
  13.5.3 SGS SA Clinical Trials Introduction
  13.5.4 SGS SA Revenue in Clinical Trials Business (2015-2020)
  13.5.5 SGS SA Recent Development
13.6 Pharmaceutical Product Development, LLC
  13.6.1 Pharmaceutical Product Development, LLC Company Details
  13.6.2 Pharmaceutical Product Development, LLC Business Overview and Its Total Revenue
  13.6.3 Pharmaceutical Product Development, LLC Clinical Trials Introduction
  13.6.4 Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2015-2020)
  13.6.5 Pharmaceutical Product Development, LLC Recent Development
13.7 Wuxi AppTec Inc.
  13.7.1 Wuxi AppTec Inc. Company Details
  13.7.2 Wuxi AppTec Inc. Business Overview and Its Total Revenue
  13.7.3 Wuxi AppTec Inc. Clinical Trials Introduction
  13.7.4 Wuxi AppTec Inc. Revenue in Clinical Trials Business (2015-2020)
  13.7.5 Wuxi AppTec Inc. Recent Development
13.8 PRA Health Sciences
  13.8.1 PRA Health Sciences Company Details
  13.8.2 PRA Health Sciences Business Overview and Its Total Revenue
  13.8.3 PRA Health Sciences Clinical Trials Introduction
  13.8.4 PRA Health Sciences Revenue in Clinical Trials Business (2015-2020)
  13.8.5 PRA Health Sciences Recent Development
13.9 Chiltern International Ltd.
  13.9.1 Chiltern International Ltd. Company Details
  13.9.2 Chiltern International Ltd. Business Overview and Its Total Revenue
  13.9.3 Chiltern International Ltd. Clinical Trials Introduction
  13.9.4 Chiltern International Ltd. Revenue in Clinical Trials Business (2015-2020)
  13.9.5 Chiltern International Ltd. Recent Development
13.10 INC Research
  13.10.1 INC Research Company Details
  13.10.2 INC Research Business Overview and Its Total Revenue
  13.10.3 INC Research Clinical Trials Introduction
  13.10.4 INC Research Revenue in Clinical Trials Business (2015-2020)
  13.10.5 INC Research Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Clinical Trials Key Market Segments
Table 2. Key Players Covered: Ranking by Clinical Trials Revenue
Table 3. Ranking of Global Top Clinical Trials Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Phase I
Table 6. Key Players of Phase II
Table 7. Key Players of Phase III
Table 8. Key Players of Phase IV
Table 9. COVID-19 Impact Global Market: (Four Clinical Trials Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Clinical Trials Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Clinical Trials Players to Combat Covid-19 Impact
Table 14. Global Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Clinical Trials Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Clinical Trials Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Clinical Trials Market Share by Regions (2015-2020)
Table 18. Global Clinical Trials Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Clinical Trials Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Clinical Trials Market Growth Strategy
Table 24. Main Points Interviewed from Key Clinical Trials Players
Table 25. Global Clinical Trials Revenue by Players (2015-2020) (Million US$)
Table 26. Global Clinical Trials Market Share by Players (2015-2020)
Table 27. Global Top Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trials as of 2019)
Table 28. Global Clinical Trials by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Clinical Trials Product Solution and Service
Table 31. Date of Enter into Clinical Trials Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Clinical Trials Market Size by Type (2015-2020) (Million US$)
Table 34. Global Clinical Trials Market Size Share by Type (2015-2020)
Table 35. Global Clinical Trials Revenue Market Share by Type (2021-2026)
Table 36. Global Clinical Trials Market Size Share by Application (2015-2020)
Table 37. Global Clinical Trials Market Size by Application (2015-2020) (Million US$)
Table 38. Global Clinical Trials Market Size Share by Application (2021-2026)
Table 39. North America Key Players Clinical Trials Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Clinical Trials Market Share (2019-2020)
Table 41. North America Clinical Trials Market Size by Type (2015-2020) (Million US$)
Table 42. North America Clinical Trials Market Share by Type (2015-2020)
Table 43. North America Clinical Trials Market Size by Application (2015-2020) (Million US$)
Table 44. North America Clinical Trials Market Share by Application (2015-2020)
Table 45. Europe Key Players Clinical Trials Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Clinical Trials Market Share (2019-2020)
Table 47. Europe Clinical Trials Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Clinical Trials Market Share by Type (2015-2020)
Table 49. Europe Clinical Trials Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Clinical Trials Market Share by Application (2015-2020)
Table 51. China Key Players Clinical Trials Revenue (2019-2020) (Million US$)
Table 52. China Key Players Clinical Trials Market Share (2019-2020)
Table 53. China Clinical Trials Market Size by Type (2015-2020) (Million US$)
Table 54. China Clinical Trials Market Share by Type (2015-2020)
Table 55. China Clinical Trials Market Size by Application (2015-2020) (Million US$)
Table 56. China Clinical Trials Market Share by Application (2015-2020)
Table 57. Japan Key Players Clinical Trials Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Clinical Trials Market Share (2019-2020)
Table 59. Japan Clinical Trials Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Clinical Trials Market Share by Type (2015-2020)
Table 61. Japan Clinical Trials Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Clinical Trials Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Clinical Trials Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Clinical Trials Market Share (2019-2020)
Table 65. Southeast Asia Clinical Trials Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Clinical Trials Market Share by Type (2015-2020)
Table 67. Southeast Asia Clinical Trials Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Clinical Trials Market Share by Application (2015-2020)
Table 69. India Key Players Clinical Trials Revenue (2019-2020) (Million US$)
Table 70. India Key Players Clinical Trials Market Share (2019-2020)
Table 71. India Clinical Trials Market Size by Type (2015-2020) (Million US$)
Table 72. India Clinical Trials Market Share by Type (2015-2020)
Table 73. India Clinical Trials Market Size by Application (2015-2020) (Million US$)
Table 74. India Clinical Trials Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Clinical Trials Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Clinical Trials Market Share (2019-2020)
Table 77. Central & South America Clinical Trials Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Clinical Trials Market Share by Type (2015-2020)
Table 79. Central & South America Clinical Trials Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Clinical Trials Market Share by Application (2015-2020)
Table 81. Quintiles IMS Company Details
Table 82. Quintiles IMS Business Overview
Table 83. Quintiles IMS Product
Table 84. Quintiles IMS Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 85. Quintiles IMS Recent Development
Table 86. Paraxel International Corporation Company Details
Table 87. Paraxel International Corporation Business Overview
Table 88. Paraxel International Corporation Product
Table 89. Paraxel International Corporation Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 90. Paraxel International Corporation Recent Development
Table 91. Charles River Laboratories Company Details
Table 92. Charles River Laboratories Business Overview
Table 93. Charles River Laboratories Product
Table 94. Charles River Laboratories Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 95. Charles River Laboratories Recent Development
Table 96. ICON plc Company Details
Table 97. ICON plc Business Overview
Table 98. ICON plc Product
Table 99. ICON plc Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 100. ICON plc Recent Development
Table 101. SGS SA Company Details
Table 102. SGS SA Business Overview
Table 103. SGS SA Product
Table 104. SGS SA Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 105. SGS SA Recent Development
Table 106. Pharmaceutical Product Development, LLC Company Details
Table 107. Pharmaceutical Product Development, LLC Business Overview
Table 108. Pharmaceutical Product Development, LLC Product
Table 109. Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 110. Pharmaceutical Product Development, LLC Recent Development
Table 111. Wuxi AppTec Inc. Company Details
Table 112. Wuxi AppTec Inc. Business Overview
Table 113. Wuxi AppTec Inc. Product
Table 114. Wuxi AppTec Inc. Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 115. Wuxi AppTec Inc. Recent Development
Table 116. PRA Health Sciences Business Overview
Table 117. PRA Health Sciences Product
Table 118. PRA Health Sciences Company Details
Table 119. PRA Health Sciences Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 120. PRA Health Sciences Recent Development
Table 121. Chiltern International Ltd. Company Details
Table 122. Chiltern International Ltd. Business Overview
Table 123. Chiltern International Ltd. Product
Table 124. Chiltern International Ltd. Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 125. Chiltern International Ltd. Recent Development
Table 126. INC Research Company Details
Table 127. INC Research Business Overview
Table 128. INC Research Product
Table 129. INC Research Revenue in Clinical Trials Business (2015-2020) (Million US$)
Table 130. INC Research Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Clinical Trials Market Share by Type: 2020 VS 2026
Figure 2. Phase I Features
Figure 3. Phase II Features
Figure 4. Phase III Features
Figure 5. Phase IV Features
Figure 6. Global Clinical Trials Market Share by Application: 2020 VS 2026
Figure 7. Interventional Case Studies
Figure 8. Observational Case Studies
Figure 9. Expanded Access Case Studies
Figure 10. Clinical Trials Report Years Considered
Figure 11. Global Clinical Trials Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Clinical Trials Market Share by Regions: 2020 VS 2026
Figure 13. Global Clinical Trials Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Clinical Trials Market Share by Players in 2019
Figure 16. Global Top Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trials as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Clinical Trials Revenue in 2019
Figure 18. North America Clinical Trials Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Clinical Trials Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Clinical Trials Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Clinical Trials Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Clinical Trials Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Clinical Trials Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Clinical Trials Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Quintiles IMS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Quintiles IMS Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 27. Paraxel International Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Paraxel International Corporation Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 29. Charles River Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Charles River Laboratories Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 31. ICON plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ICON plc Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 33. SGS SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. SGS SA Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 35. Pharmaceutical Product Development, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Pharmaceutical Product Development, LLC Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 37. Wuxi AppTec Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Wuxi AppTec Inc. Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 39. PRA Health Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. PRA Health Sciences Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 41. Chiltern International Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Chiltern International Ltd. Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 43. INC Research Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. INC Research Revenue Growth Rate in Clinical Trials Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed


More Publications